Literature DB >> 20220049

Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy.

Keijiro Ishikawa1, Shigeo Yoshida, Koji Kadota, Takanori Nakamura, Hiroaki Niiro, Satoshi Arakawa, Ayako Yoshida, Koichi Akashi, Tatsuro Ishibashi.   

Abstract

PURPOSE: To determine a profile of gene expression in retinas of a murine model of oxygen-induced retinopathy (OIR).
METHODS: OIR was induced in C57BL/6N mice by exposing postnatal day (P)7 pups to 75% oxygen for 5 days and then returning them to room air at P12. Gene microarrays containing more than 47,000 transcripts were used to study the changes in gene expression in retinas isolated immediately (P12) and at 12 hours (P12.5) after exposure to hyperoxia. The retinas of P12 mice raised under normoxic conditions served as control subjects. Quantitative RT-PCR and multiplex ELISA were performed to validate the microarray analyses.
RESULTS: The expression of 83 gene transcripts was significantly altered in the hyperoxic P12 retinas. These genes were classified as cellular components or were associated with development, metabolism, transport, stress response, cell adhesion, inflammation, or vision. The genes related to retinal growth, such as Pdgfb and Robo4, which are associated with vascular development, were downregulated. In contrast, the expression levels of 95 genes were significantly altered in the hypoxic P12.5 retinas, which contained several known hypoxia-regulated genes including Vegfa and Hif1a. The differentially expressed genes were broadly clustered into the development, inflammation, metabolism, signaling, antiapoptosis, cellular component, transport, glycolysis, and vision groups. Those associated with organogenesis (e.g., Vegfa, Igfbp3, Tnfrsf12a, and Nestin) and to inflammation (e.g., Ccl3, Ccl4, and MHCs) were upregulated. The results of quantitative RT-PCR and multiplex ELISA were in agreement with the microarray data.
CONCLUSIONS: These alterations in gene expression may determine the hyperoxic growth retardation, postischemic inflammation, neovascularization, and remodeling in retinas of murine OIR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220049     DOI: 10.1167/iovs.09-4605

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

1.  Increased expression of nestin in human pterygial epithelium.

Authors:  Dan Wen; Hua Wang; Boon Chin Heng; Hua Liu
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

2.  TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.

Authors:  Hossein Ameri; Hua Liu; Rong Liu; Yonju Ha; Adriana A Paulucci-Holthauzen; Shuqun Hu; Massoud Motamedi; Bernard F Godley; Ronald G Tilton; Wenbo Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

Review 3.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

4.  Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.

Authors:  Wenbo Zhang; Harumasa Yokota; Zhimin Xu; Subhadra P Narayanan; Lauren Yancey; Akitoshi Yoshida; Dennis M Marcus; Robert W Caldwell; Ruth B Caldwell; Steven E Brooks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

Review 5.  Anti-inflammatory therapy for diabetic retinopathy.

Authors:  Wenbo Zhang; Hua Liu; Modesto Rojas; Robert W Caldwell; Ruth B Caldwell
Journal:  Immunotherapy       Date:  2011-05       Impact factor: 4.196

6.  Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.

Authors:  T Nakama; S Yoshida; K Ishikawa; Y Kobayashi; Y Zhou; S Nakao; Y Sassa; Y Oshima; K Takao; A Shimahara; K Yoshikawa; T Hamasaki; T Ohgi; H Hayashi; A Matsuda; A Kudo; M Nozaki; Y Ogura; M Kuroda; T Ishibashi
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

7.  Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity.

Authors:  Rachel M Griffith; Hu Li; Nan Zhang; Tara L Favazza; Anne B Fulton; Ronald M Hansen; James D Akula
Journal:  Doc Ophthalmol       Date:  2013-06-18       Impact factor: 2.379

Review 8.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

Review 9.  An ocular view of the IGF-IGFBP system.

Authors:  Dung V Nguyen; Sergio Li Calzi; Lynn C Shaw; Jennifer L Kielczewski; Hannah E Korah; Maria B Grant
Journal:  Growth Horm IGF Res       Date:  2013-04-08       Impact factor: 2.372

Review 10.  Vitreous mediators in retinal hypoxic diseases.

Authors:  Roberto dell'Omo; Francesco Semeraro; Giulio Bamonte; Francesco Cifariello; Mario R Romano; Ciro Costagliola
Journal:  Mediators Inflamm       Date:  2013-01-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.